1999 perspective in drug industry: Drug revaluation and PMS
Published: 1999-01-19 14:26:00
Updated: 1999-01-19 14:26:00
The new drug revaluation system implemented from 1995 seems to be substantially eased and converted to the PMS (Post marketing surveillance) after strengthening the revaluation and the monitoring of drug adverse reactions, the KFDA said.
The KFDA recognized that the drug revaluation system raise...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
